Omniscan intelligence · 1 August 2026–31 August 2026
UK pharma media reputation tracker
Compare share of voice, sentiment and themes for GSK, AstraZeneca, Pfizer and 7 peers across 898 UK earned-media mentions, Aug–Aug 2026.
- Reporting period
- 1 August 2026–31 August 2026
- Articles analysed
- 886
- Earned-media mentions
- 898
- Organisations compared
- 10
Organisations in the benchmark
- GSK
- AstraZeneca
- Pfizer
- Eli Lilly
- Novartis
- MSD
- Roche
- Sanofi
- Novo Nordisk
- Moderna
What the benchmark compares
Explore share of voice, monthly visibility, coverage volume, positive and negative sentiment, net media tone and editorial themes. Compare the full cohort, then open an organisation-level deep dive for its news-cycle movement, leading themes and coverage evidence.
AstraZeneca led average share of voice at 35%.